Advisor Group Holdings, Inc. Abbott Laboratories Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 349,726 shares of ABT stock, worth $39.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

349,726

Previous 324,980 7.61%

Holding current value

$39.7 Million

Previous $33.8 Million 18.08%

% of portfolio

0.09%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $2.48 Million - $2.92 Million	24,746 Added 7.61%	349,726 $39.9 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $6.59 Million - $7.36 Million	-65,449 Reduced 16.76%	324,980 $33.8 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $22.8 Million - $25.2 Million	-208,615 Reduced 34.82%	390,429 $44.4 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $19.7 Million - $24.1 Million	-218,400 Reduced 26.72%	599,044 $65.9 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $16.3 Million - $19.5 Million	170,147 Added 26.29%	817,444 $79.2 Million
Q2 2023 Aug 21, 2023	SELL	$100.78 - $112.29 $6.78 Million - $7.56 Million	-67,297 Reduced 9.42%	647,297 $70.6 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $6.3 Million - $7.01 Million	62,469 Added 9.58%	714,594 $77.9 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $2.26 Million - $2.66 Million	23,363 Added 3.72%	652,125 $66 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $4.35 Million - $5.11 Million	45,800 Added 7.86%	628,762 $69 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.6 Million - $1.85 Million	16,520 Added 2.92%	582,962 $56.4 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $1.47 Million - $1.77 Million	-14,369 Reduced 2.47%	566,442 $61.6 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $1.67 Million - $2.04 Million	14,639 Added 2.59%	580,811 $71.8 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $2.92 Million - $3.23 Million	25,033 Added 4.63%	566,172 $66.9 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $1.27 Million - $1.49 Million	11,974 Added 2.26%	541,139 $62.8 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $1.53 Million - $1.81 Million	14,099 Added 2.74%	529,165 $63.4 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $1.65 Million - $1.8 Million	-15,738 Reduced 2.96%	515,066 $56.4 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $2.58 Million - $3.13 Million	28,147 Added 5.6%	530,804 $57 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $34.4 Million - $44.1 Million	-449,492 Reduced 47.21%	502,657 $46 Million
Q1 2020 May 18, 2020	BUY	$62.82 - $91.86 $59.8 Million - $87.5 Million	952,149 New	952,149 $38.6 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Abbott Laboratories Transaction History